96 related articles for article (PubMed ID: 27984104)
1. Hyperthermia-triggered drug delivery from iRGD-modified temperature-sensitive liposomes enhances the anti-tumor efficacy using high intensity focused ultrasound.
Deng Z; Xiao Y; Pan M; Li F; Duan W; Meng L; Liu X; Yan F; Zheng H
J Control Release; 2016 Dec; 243():333-341. PubMed ID: 27984104
[TBL] [Abstract][Full Text] [Related]
2. Targeted antibiotic delivery using low temperature-sensitive liposomes and magnetic resonance-guided high-intensity focused ultrasound hyperthermia.
Wardlow R; Bing C; VanOsdol J; Maples D; Ladouceur-Wodzak M; Harbeson M; Nofiele J; Staruch R; Ramachandran A; Malayer J; Chopra R; Ranjan A
Int J Hyperthermia; 2016 May; 32(3):254-64. PubMed ID: 26892114
[TBL] [Abstract][Full Text] [Related]
3. Dual targetable drug delivery system based on cell membrane camouflaged liposome for enhanced tumor targeting and improved anti-tumor efficiency.
Duan M; Zhou D; Ke J; Chen Y; Wu W; Li Y; Ren J; Wang L; Zhang Z; Wang C
Colloids Surf B Biointerfaces; 2024 Jun; 238():113892. PubMed ID: 38581834
[TBL] [Abstract][Full Text] [Related]
4. Replication Study: Coadministration of a tumor-penetrating peptide enhances the efficacy of cancer drugs.
Mantis C; Kandela I; Aird F;
Elife; 2017 Jan; 6():. PubMed ID: 28100395
[TBL] [Abstract][Full Text] [Related]
5. In vivo evaluation of CD38 and CD138 as targets for nanoparticle-based drug delivery in multiple myeloma.
Omstead DT; Mejia F; Sjoerdsma J; Kim B; Shin J; Khan S; Wu J; Kiziltepe T; Littlepage LE; Bilgicer B
J Hematol Oncol; 2020 Nov; 13(1):145. PubMed ID: 33138841
[TBL] [Abstract][Full Text] [Related]
6. Ultrasound-responsive highly biocompatible nanodroplets loaded with doxorubicin for tumor imaging and treatment
Zhou X; Guo L; Shi D; Meng D; Sun X; Shang M; Liu X; Zhao Y; Li J
Drug Deliv; 2020 Dec; 27(1):469-481. PubMed ID: 32166985
[TBL] [Abstract][Full Text] [Related]
7. Metal-Organic Framework-Mediated Synergistic Hypoxia-Activated Chemo-Immunotherapy Induced by High Intensity Focused Ultrasound for Enhanced Cancer Theranostics.
Sun T; Li J; Zhou Y; Zeng C; Luo C; Luo X; Li H
Small; 2024 May; 20(18):e2306338. PubMed ID: 38072817
[TBL] [Abstract][Full Text] [Related]
8. A Disposable Microfluidic Device for Controlled Drug Release from Thermal-Sensitive Liposomes by High Intensity Focused Ultrasound.
Meng L; Deng Z; Niu L; Li F; Yan F; Wu J; Cai F; Zheng H
Theranostics; 2015; 5(11):1203-13. PubMed ID: 26379786
[TBL] [Abstract][Full Text] [Related]
9. Tumor-penetrating iRGD facilitates penetration of poly(floxuridine-ketal)-based nanomedicine for enhanced pancreatic cancer therapy.
Li X; Zhong H; Zheng S; Mu J; Yu N; Guo S
J Control Release; 2024 May; 369():444-457. PubMed ID: 38575076
[TBL] [Abstract][Full Text] [Related]
10. Bifunctional iRGD-Exo-DOX crosses the blood-brain barrier to target central nervous system lymphoma.
Xia T; Liu Z; Du Y; Zhang J; Liu X; Ouyang J; Xu P; Chen B
Biochem Pharmacol; 2024 May; 223():116138. PubMed ID: 38494062
[TBL] [Abstract][Full Text] [Related]
11. A Doxorubicin-Glucuronide Prodrug Released from Nanogels Activated by High-Intensity Focused Ultrasound Liberated β-Glucuronidase.
Besse HC; Chen Y; Scheeren HW; Metselaar JM; Lammers T; Moonen CTW; Hennink WE; Deckers R
Pharmaceutics; 2020 Jun; 12(6):. PubMed ID: 32532061
[TBL] [Abstract][Full Text] [Related]
12. Nanoparticles coated with the tumor-penetrating peptide iRGD reduce experimental breast cancer metastasis in the brain.
Hamilton AM; Aidoudi-Ahmed S; Sharma S; Kotamraju VR; Foster PJ; Sugahara KN; Ruoslahti E; Rutt BK
J Mol Med (Berl); 2015 Sep; 93(9):991-1001. PubMed ID: 25869026
[TBL] [Abstract][Full Text] [Related]
13. iRGD Peptide as a Tumor-Penetrating Enhancer for Tumor-Targeted Drug Delivery.
Kang S; Lee S; Park S
Polymers (Basel); 2020 Aug; 12(9):. PubMed ID: 32847045
[TBL] [Abstract][Full Text] [Related]
14. Clinical trial protocol for TARDOX: a phase I study to investigate the feasibility of targeted release of lyso-thermosensitive liposomal doxorubicin (ThermoDox®) using focused ultrasound in patients with liver tumours.
Lyon PC; Griffiths LF; Lee J; Chung D; Carlisle R; Wu F; Middleton MR; Gleeson FV; Coussios CC
J Ther Ultrasound; 2017; 5():28. PubMed ID: 29118984
[TBL] [Abstract][Full Text] [Related]
15. iRGD-targeted Physalis Mottle Virus-like Nanoparticles for Targeted Cancer Delivery.
Barkovich KJ; Zhao Z; Steinmetz NF
Small Sci; 2023 Aug; 3(8):. PubMed ID: 38465197
[TBL] [Abstract][Full Text] [Related]
16. MT1-MMP-Activated Liposomes to Improve Tumor Blood Perfusion and Drug Delivery for Enhanced Pancreatic Cancer Therapy.
Wei Y; Song S; Duan N; Wang F; Wang Y; Yang Y; Peng C; Li J; Nie D; Zhang X; Guo S; Zhu C; Yu M; Gan Y
Adv Sci (Weinh); 2020 Sep; 7(17):1902746. PubMed ID: 32995113
[TBL] [Abstract][Full Text] [Related]
17. Hyperthermia and Temperature-Sensitive Nanomaterials for Spatiotemporal Drug Delivery to Solid Tumors.
Amin M; Huang W; Seynhaeve ALB; Ten Hagen TLM
Pharmaceutics; 2020 Oct; 12(11):. PubMed ID: 33105816
[TBL] [Abstract][Full Text] [Related]
18. Targeted drug delivery using iRGD peptide for solid cancer treatment.
Liu X; Jiang J; Ji Y; Lu J; Chan R; Meng H
Mol Syst Des Eng; 2017 Oct; 2(4):370-379. PubMed ID: 30498580
[TBL] [Abstract][Full Text] [Related]
19. Sequential HIFU heating and nanobubble encapsulation provide efficient drug penetration from stealth and temperature sensitive liposomes in colon cancer.
VanOsdol J; Ektate K; Ramasamy S; Maples D; Collins W; Malayer J; Ranjan A
J Control Release; 2017 Feb; 247():55-63. PubMed ID: 28042085
[TBL] [Abstract][Full Text] [Related]
20. iRGD conjugated nimbolide liposomes protect against endotoxin induced acute respiratory distress syndrome.
Pooladanda V; Thatikonda S; Sunnapu O; Tiwary S; Vemula PK; Talluri MVNK; Godugu C
Nanomedicine; 2021 Apr; 33():102351. PubMed ID: 33418136
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
